Simulations Plus, Inc. (NASDAQ:SLP) Given Consensus Recommendation of “Buy” by Analysts

Shares of Simulations Plus, Inc. (NASDAQ:SLP) have been assigned a consensus recommendation of “Buy” from the seven research firms that are currently covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a hold rating, five have given a buy rating and one has assigned a strong buy rating to the company. The average 12-month target price among brokers that have updated their coverage on the stock in the last year is $49.40.

Several research analysts have recently commented on the company. KeyCorp boosted their price target on Simulations Plus from $35.00 to $37.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. William Blair reissued an “outperform” rating on shares of Simulations Plus in a research report on Wednesday, January 8th.

Simulations Plus Trading Up 3.6 %

Shares of SLP stock opened at $25.56 on Friday. Simulations Plus has a twelve month low of $24.00 and a twelve month high of $51.22. The stock has a market capitalization of $513.55 million, a price-to-earnings ratio of 63.90 and a beta of 0.89. The stock has a fifty day simple moving average of $31.29 and a two-hundred day simple moving average of $30.88.

Insider Activity at Simulations Plus

In related news, Director Walter S. Woltosz sold 20,000 shares of the company’s stock in a transaction dated Monday, February 3rd. The stock was sold at an average price of $33.91, for a total transaction of $678,200.00. Following the transaction, the director now directly owns 3,402,584 shares of the company’s stock, valued at $115,381,623.44. This represents a 0.58 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. 19.40% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the business. First Horizon Advisors Inc. increased its position in Simulations Plus by 82.6% during the 3rd quarter. First Horizon Advisors Inc. now owns 818 shares of the technology company’s stock valued at $26,000 after buying an additional 370 shares in the last quarter. Jones Financial Companies Lllp increased its position in Simulations Plus by 53.6% during the 4th quarter. Jones Financial Companies Lllp now owns 1,223 shares of the technology company’s stock valued at $34,000 after buying an additional 427 shares in the last quarter. Johnson Financial Group Inc. purchased a new stake in Simulations Plus during the 4th quarter valued at about $39,000. Quantbot Technologies LP purchased a new stake in Simulations Plus during the 3rd quarter valued at about $59,000. Finally, Tower Research Capital LLC TRC grew its stake in Simulations Plus by 42.2% during the 4th quarter. Tower Research Capital LLC TRC now owns 2,575 shares of the technology company’s stock valued at $72,000 after purchasing an additional 764 shares during the last quarter. 78.08% of the stock is owned by institutional investors and hedge funds.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.